ODYY (Odyssey Group International) Risk Assessment

View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Odyssey Group International is: No Data: Cannot be evaluated.

Competitive Comparison of Odyssey Group International's Risk Assessment

For the Medical Devices subindustry, Odyssey Group International's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Odyssey Group International's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Group International's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Odyssey Group International's Risk Assessment falls into.

Odyssey Group International (OTCPK:ODYY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Odyssey Group International Risk Assessment Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Odyssey Group International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102

Website

https://www.odysseyhealthinc.com

Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. The company have two different technologies in the research and development stage; the CardioMap heart monitoring and screening device, and the Save a Life choking rescue device.

Executives

Erik C. Emerson	other: Chief Commercial Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda	other: Chief Operating Officer	2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson	director	2372 MORSE AVE., IRVINE CA 92614
Christine Farrell	officer: Controller/Secretary	2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo	director	62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey	director	2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy	director	2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d	director	2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond	director, officer: President/CEO	10 CANTERBURY ROAD, WINDHAM NH 03087